A detailed history of Evoke Wealth, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Evoke Wealth, LLC holds 10,550 shares of GKOS stock, worth $1.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
10,550
Holding current value
$1.6 Million
% of portfolio
0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$113.62 - $135.39 $1.2 Million - $1.43 Million
10,550 New
10,550 $1.37 Billion
Q3 2022

Nov 07, 2022

BUY
$46.84 - $58.49 $892,067 - $1.11 Million
19,045 Added 443.73%
23,337 $1.24 Million
Q1 2021

May 13, 2021

BUY
$70.43 - $97.42 $106,631 - $147,493
1,514 Added 54.5%
4,292 $360,000
Q3 2019

Nov 12, 2019

BUY
$58.58 - $83.91 $162,735 - $233,101
2,778 New
2,778 $174 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.2B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Evoke Wealth, LLC Portfolio

Follow Evoke Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evoke Wealth, LLC with notifications on news.